WITH ANSWERS 2024/2025
A full reversible agonist differs from a competitive antagonist in that ______. - ANSWER-A
reversible agonist binds to Rs, activates a second message and dissociates from the receptor
showing positive intrinsic activity, whereas a noncompetitive antagonist does not bind to the
same Rs as NTs and produces zero intrinsic activity.
A major concept underlying at what amount drugs produce their effects is called dose-response.
How are the amount of a drug and the effect it produces generally related? - ANSWER-The
quantitative relationship is summarized as "Too little an amount of a drug = no/minimal effect;
the ED50 does = desired effect; too high a dose = undesired effects (aversive/toxic dose)
According to the models and characteristics illustrated in Table 5.3, a theory of addiction model
that does not emphasize reinforcement learning, reward, discrimination of stimuli, goal -directed
behaviors, drive theory, or latent inhibition is ______. - ANSWER-The medical disease model
Another name for psychopharmacology, a field that bridges concepts of pharmacology and
psychology is - ANSWER-Behavioral pharmacology
Cross tolerance is a term that refers to when - ANSWER-Two different drugs share a common
mechanism of action, and thus to be tolerant to the first drug also generates tolerance to the
second drug even if the second drug was never administered.
Ethical cost - ANSWER-assessment that weighs the value of potential research discoveries
against the potential pain and distress experienced by research subjects
Minimally, which three aspects of human experience are affected by "psychoactive drugs?" -
ANSWER-Thinking, mood and behavior
, objective effects - ANSWER-
Once a person is addicted to a substance, and they go abstinent, they remain predisposed
(mentally and physiologically/genetically) to drug use rather than returning to a point of cure
that precludes relapsing. Why? - ANSWER-Treatments have yet to be developed that reverse the
lasting effects of drug addiction, and whereas a person can be in remission, relapse always
remains a possibility.
open-label studies - ANSWER-assignment of study treatments without using blinded procedures
Other than functioning as an agonist to mimic NT effects at Rs other drugs can act to enhance NT
activity (such as entacapone) by... - ANSWER-Binding to and inhibitng the enzyme that breaks
down the NT dopamine.
pharmacodynamics - ANSWER-
pharmacogenetics - ANSWER-
pharmacokinetics - ANSWER-
Pharmocotherapeutics - ANSWER-
Potency - ANSWER-
psychoactive drugs - ANSWER-
psychopharmacology - ANSWER-